Moreover, reducing intracellular K+ via overexpression of KCa3.1 can increase the production of IFNγ in T cells to inhibit tumor growth and prolong survival, which is proved in patients with head and neck cancer (26, 53). This evidence concerns the gene IFNG and neoplasm.